Use of Human Umbilical Cord Blood-Derived Progenitor Cells for Tissue-Engineered Heart Valves

Importantly, this study demonstrates in vitro generation of viable human heart valves based on CD133+ cells derived from umbilical cord blood. These findings constitute a significant step forward in the development of new clinical strategies for the treatment of congenital defects.